KLT-1101

N/A

Report date: 2024/12/31 14:55:42

Base Information

Drug NameKLT-1101
Drug Alias Name重组人白介素-12注射液（CHO细胞）recombinant human interleukin 12（CHO细胞）KLT-1101
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-12 receptor stimulants
TargetsInterleukin-12 receptor
Therapy Area/IndicationsSolid tumoursLeukopeniaThrombocytopenia +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesKang Litai Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesKanglitai Biomedicine (Qingdao) Co LtdKang Litai Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursThrombocytopeniaMelanoma +[4] 
Inactive IndicationsLeukopenia

Other Information

ATC CodeN/A
Related LinksN/A